文献速递呼吸衰竭与机械通气心脑血管急症

DAGMAR评分:D-二聚体检测引导的校正风险调节,提高D-二聚体对肺栓塞的特异性

The DAGMAR Score: D-dimer assay-guided moderation of adjusted risk. Improving specificity of the D-dimer for pulmonary embolism.
PubMed 文献 · Am J Emerg Med · 2018-08-08
一句话结论在疑似肺栓塞患者中,DAGMAR评分<2分时总体肺栓塞风险<1.2%,特异性从38%提高到59%而不损害敏感性(94%到96%)。

本研究回顾性分析了2012年6月4日至2016年3月30日急诊科18岁及以上同时开具D-二聚体和影像学检查的患者数据。通过两次多元回归分析,确定与肺栓塞或D-二聚体阳性显著相关的因素,并赋予正负分值,结合年龄和血小板调整,开发了DAGMAR评分。在8486次就诊中,3523次为有影像学检查的唯一就诊,其中2253次(26.5%)D-二聚体阳性,完成3501次CT和156次VQ扫描,检出198例肺栓塞。DAGMAR评分<2分时总体肺栓塞风险<1.2%;特异性从38%提高到59%,敏感性从94%提高到96%。使用DAGMAR评分可使CT扫描从2253次减少到1556次,并减少假阴性结果。

要点

  • 在疑似肺栓塞急诊患者中,DAGMAR评分<2分对应总体肺栓塞风险<1.2%。
  • DAGMAR评分将特异性从38%提高到59%,同时敏感性从94%提高到96%。
  • 使用DAGMAR评分可使CT扫描从2253次减少到1556次,并减少假阴性结果。
  • 评分基于年龄、血小板调整及与肺栓塞和D-二聚体升高相关的因素,正负分值分别对应肺栓塞预测和D-二聚体阳性预测。

适用人群与场景

  • 急诊科18岁及以上患者,同时开具D-二聚体和影像学检查(CT或VQ),时间范围为2012年6月4日至2016年3月30日。

诊断标准与关键阈值

  • DAGMAR评分<2分对应总体肺栓塞风险<1.2%。

研究设计与关键结果

  • 回顾性电子病历数据分析,共审查8486次就诊,其中3523次为有影像学检查的唯一就诊,2253次(26.5%)D-二聚体阳性。
  • 完成3501次CT扫描和156次VQ扫描,检出198例肺栓塞。
  • DAGMAR评分<2分时总体肺栓塞风险<1.2%。
  • 特异性从38%提高到59%,敏感性从94%提高到96%。
  • 使用DAGMAR评分可使CT扫描从2253次减少到1556次,并减少假阴性结果。

证据类型、等级与局限

  • 证据类型:回顾性电子病历数据分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在疑似肺栓塞急诊患者中,DAGMAR评分<2分时总体肺栓塞风险<1.2%,可考虑用于减少CT扫描(从2253次减少到1556次)而不损害敏感性(从94%提高到96%)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

We generated a novel scoring system to improve the test characteristics of D-dimer in patients with suspected PE (pulmonary emboli). Electronic Medical Record data were retrospectively reviewed on Emergency Department (ED) patients 18 years or older for whom a D-dimer and imaging were ordered between June 4, 2012 and March 30, 2016. Symptoms (dyspnea, unilateral leg swelling, hemoptysis), age, vital signs, medical history (cancer, recent surgery, medications, history of deep vein thrombosis or PE, COPD, smoking), laboratory values (quantitative D-dimer, platelets, and mean platelet volume (MPV)), and imaging results (CT, VQ) were collected. Points were designated to factors that were significant in two multiple regression analyses, for PE or positive D-dimer. Points predictive of PE were designated positive values and points predictive of positive D-dimer, irrespective of presence of PE, were designated negative values. The DAGMAR (D-dimer Assay-Guided Moderation of Adjusted Risk) score was developed using age and platelet adjustment and points for factors associated with PE and elevated D-dimer. Of 8486 visits reviewed, 3523 were unique visits with imaging, yielding 2253 (26.5%) positive D-dimers. 3501 CT scans and 156 VQ scans were completed, detecting 198 PE. In our cohort, a DAGMAR Score < 2 equated to overall PE risk < 1.2%. Specificity improved (38% to 59%) without compromising sensitivity (94% to 96%). Use of the DAGMAR Score would have reduced CT scans from 2253 to 1556 and lead to fewer false negative results. By considering factors that affect D-dimer and also PE, we improved specificity without compromising sensitivity.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Glober N, Tainter CR, Brennan J, et al. The DAGMAR Score: D-dimer assay-guided moderation of adjusted risk. Improving specificity of the D-dimer for pulmonary embolism. Am J Emerg Med. 2018. PMID: 30104092. doi:10.1016/j.ajem.2018.08.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。